FDA
approval
· 2024-04-05
FDA Approved: XCOPRI — Supplemental Application (SK Life Science, Inc.)
Summary
The FDA granted a supplemental approval for XCOPRI (cenobamate) from SK Life Science, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for XCOPRI (CENOBAMATE)